1 |
Arora, S., J. Ali, A. Ahuja, R. K. Khar, and S. Baboota (2005) Floating drug delivery systems: A review. AAPS Pharm. Sci. Tech. 6: 372-390.
DOI
|
2 |
Kadivar, A., B. Kamlidehghan, H. A. Javar, E. T. Davoudi, N. D. Zaharuddin, B. Sabeti, L. Y. Chung, and M. I. Noordin (2015) Formulation and in vitro, in vivo evaluation of effervescent floating sustained release imatinib mesylate tablet. PLOS One. 10: e0126874.
DOI
|
3 |
Kumar, N., S. Soni, T. Singh, A. Kumar, F. J. Ahmad, A. Bhatnagar, and G. Mittal (2015) Development and optimization of gastroretentive controlled-release tablet of calcium-disodium edetate and its in vivo gamma scintigraphic evaluation. AAPS Pharm. Sci. Tech. 16: 1270-1280.
DOI
|
4 |
Patel, D. M., M. J. Patel, A. N. Patel, and C. N. Patel (2011) Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine. Int. J. Pharm. Investig. 1: 247-254.
DOI
|
5 |
Sharma, N., N. Jain, S. CK, and S. Jain (2012) Formulation and evaluation of gastric retensive floating tablets containing Cefpodoxime proxetil solid dispersions. Int. J. Curr. Pharm. Res. 4: 82-87.
|
6 |
Bechgaard, H. and K. Ladefoged (1978) Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J. Pharm. Pharmacol. 30: 690-692.
DOI
|
7 |
Vervaet C., L. Baert, and J. P. Remon (1995) Extrusion-spheronization: A literature review. Int. J. Pharm. 116: 131-146.
DOI
|
8 |
Shep, S., S. Dodiya, S. Lahoti, and R. Mayee (2011) Swelling system: a novel approach towards gastroretentive drug delivery system. Indo-Global J. Pharm. Sci. 1: 234-242.
|
9 |
Mamajek, R. C. and E. S. Moyer (1980) Drug-dispensing device and method. US Patent 4,207,890.
|
10 |
Urquhart, J. and F. Theeuwes (1984) Drug delivery system comprising a reservoir containing a plurality of tiny pills. US Patent 4,434,153.
|
11 |
Singh, B. N. and K. H. Kim (2000) Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J. Control Release. 63: 235-259.
DOI
|
12 |
Solanki, N. D., S. Shah, J. Patel, and P. Upadhyay (2013) Formulation and evaluation of once a day bilayer floating tablet of antihypertensive drug involving dissolution enhancement approach. Der Pharmacia Sinica. 4: 54-66.
|
13 |
Saito, N., K. Konishi, F. Sato, M. Kato, H. Takeda, T. Sugiyama, and M. Asaka (2003) Plural transformation-processes from spiral to coccoid Helicobacter pylori and its viability. J. Infect. 46: 49-55.
DOI
|
14 |
Park, K. N. and J. R. Robinson (1984) Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 19: 107-127.
DOI
|
15 |
Cockburn, J., A. L. Reid, J. A. Bowman, and R. W. Sanson-Fisher (1987) Effects of intervention on antibiotic compliance in patients in general practice. Med. J. Aust. 147: 324-328.
|
16 |
Chitnis, V. S., V. S. Malshe, and J. K. Lalla (1991) Bioadhesive polymers-synthesis, evaluation and application in controlled release tablets. Drug Dev. Ind. Pharm. 17: 879-892.
DOI
|
17 |
Hingmire, L. P. and D. M. Sakarkar (2013) Formulation and evaluation of Valsartan SR tablets using hydrophilic and hydrophobic polymer. J. Chem. Pharm. Sci. 6: 254-260.
|
18 |
Ha, N. S., T. T. Tran, P. H. Tran, J. B. Park, and B. J. Lee (2011) Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly watersoluble valsartan. Chem. Pharm. Bull. 59: 844-880.
DOI
|
19 |
Xu, W. J., Y. Liu, L. L. Shi, J. H. Cui, and Q. R. Cao (2014) In vitro dissolution and physicochemical characterizations of novel PVPbased solid dispersion containing valsartan prepared by a freezedrying method. J. Pharm. Sci. 27: 1799-1804.
|
20 |
Serajuddin, A. T. M. (1999) Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88: 1058-1066.
DOI
|
21 |
Siepmann, J. and N. A. Peppas (2001) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48: 139-157.
DOI
|
22 |
US Pharmacopoeia National Formulary (2003) USP 26-NF21. 3rd ed., pp. 2439. Mack Printing Company, Easton, USA.
|
23 |
Ministry of Food and Drug Safety, Guideline on validation of analytical procedure. http://www.mfds.go.kr. (2015).
|
24 |
Talegaonikar, S., A. Y. Khan, R. K. Khar, F. J. Ahmad, and Z. Khan (2007) Development and characterization of Paracetamol complexes with hydroxypropyl -cyclodextrin. Iranian J. Pharm. Res. 6: 95-99.
|
25 |
Baboota, S., M. Dhaliwal, and K. Kohli (2005) Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of Rofecoxib-cyclodextrin inclusion compounds. Preparation and properties of Rofecoxib hydroxypropyl -cyclodextrin inclusion complex: A technical note. AAPS Pharm. Sci. Tech. 6: 83-90.
DOI
|
26 |
Fouladi, F. and S. A. Mortazavi (2012) Preparation and in vitro evaluation of gastroretensive Bupropion hydrochloride tablets. Trop. J. Pharm. Res. 11: 351-359.
|
27 |
Ritger, P. L. and N. A. Peppas (1987) A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Controll. Rel. 5: 37-42.
DOI
|
28 |
Chen, R. N., H. O. Ho, C. Y. Yu., and M. T. Sheu (2010) Development of swelling / floating gastroretensive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism. Eur. J. Pharm. Sci. 39: 82-89.
DOI
|